They found that RIP 1 and MLKL concentrations were higher in patients with more severe NASH (activity score ≥ 2) compared with patients with milder NASH (activity score < 2) (9). This evidence concerns the gene MLKL and metabolic dysfunction-associated steatohepatitis.